Alphapointe received notice from the United States Patent and Trademark Office that the organization’s application for a patent for the Junctional Hemorrhage Control Plate has been formally approved. The patent approval is the latest in a series of developments for Alphapointe’s Tactical/Medical Division, which now has eight patents/patent-pending products designed to improve the well-being and…
